Pacer Advisors, Inc. Kura Oncology, Inc. Transaction History

Pacer Advisors, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$17.53 - $22.98 $13,007 - $17,051	-742 Reduced 51.14%	709 $14,000
Q1 2024 May 10, 2024	BUY	$13.42 - $23.53 $19,472 - $34,142	1,451 New	1,451 $30,000
Q2 2021 Jul 21, 2021	SELL	$20.85 - $29.88 $54,585 - $78,225	-2,618 Closed	0 $0
Q1 2021 Apr 05, 2021	SELL	$24.75 - $39.14 $13,810 - $21,840	-558 Reduced 17.57%	2,618 $74,000
Q4 2020 Jan 20, 2021	BUY	$29.0 - $41.62 $52,316 - $75,082	1,804 Added 131.49%	3,176 $104,000
Q3 2020 Oct 19, 2020	BUY	$16.3 - $30.64 $22,363 - $42,038	1,372 New	1,372 $42,000
Q4 2018 Feb 13, 2019	SELL	$10.6 - $17.49 $26,690 - $44,039	-2,518 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$16.65 - $21.85 $41,924 - $55,018	2,518 New	2,518 $44,000

185

81.8M

42.1K

34K

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $598M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.